ClinOne Closes Series A Funding Round
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
By Colin Kellaher Pfizer Inc. on Tuesday said the U.S. Food and Drug Administration has accepted for review applications seeking expanded approval of the combination of its Braftovi and... | April 4, 2023
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 ...
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay
Pfizer plans to let the biotech drug developer continue innovating, except with more resources. Seagen's key products use monoclonal antibodies that help deliver a cancer-killing drug while sparing surrounding tissue.